Food Pharma India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.50 Cr
- Revenue Growth -74.97%
- Profit Growth -88.27%
- Ebitda 94.53%
- Net Worth 0.44%
- Total Assets 7.13%
About Food Pharma India
Food Pharma India Private Limited (FPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 August 1995 and has a history of 29 years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹3.50 Cr.
Kamlesh Aiya and Vijay Aiya serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH1995PTC091350
- Company No.
091350
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1995
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Food Pharma India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamlesh Aiya  | Managing Director | 22-Dec-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Aiya | Director | 12-Nov-2009 | Current |
Financial Performance of Food Pharma India.
Food Pharma India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 74.97% decrease. The company also saw a substantial fall in profitability, with a 88.27% decrease in profit. The company's net worth moved up by a moderate rise of 0.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Food Pharma India?
In 2019, Food Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shabbir And Brothers Trading Private LimitedKamlesh Aiya is a mutual person
Charges (Loans)
₹35.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 2.00 Cr
- Axis Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2009 | Bank Of Maharashtra | ₹2.00 Cr | Open |
| 31 May 2006 | Axis Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Food Pharma India?
Unlock and access historical data on people associated with Food Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Food Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Food Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
